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Edited by Vladimir SkulachevAbstract Monocytic cell lines have been extensively used to
characterize and model various features of the atherogenic pro-
cess. We found striking diﬀerences in the apoptotic pathways
of U937 cells and THP-1 cells exposed to copper-oxidized
LDL. While phosphatidylserine exposure occurred in both lines,
caspase activation was only apparent in the THP-1 cells.
OxLDL caused caspase activity to decrease below that seen in
untreated U937 cells, and this corresponded with a loss in intra-
cellular thiols. In conclusion, exposure of U937 cells to oxLDL
did not trigger a conventional apoptosis response, but still
resulted in phosphatidylserine externalization.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Oxidized low density lipoprotein1. Introduction
The presence of a necrotic core is a key feature in advanced
atherosclerotic plaques. This necrotic core region appears to be
formed through the death of both macrophages and smooth
muscle cells deep within the plaque [1–3]. The lysis of these
cells results in the release of cellular components and may be
the source of the cholesterol deposits found within advanced
atherosclerotic plaques.
The oxidized low density lipoprotein (oxLDL) has been
implicated as a key initiator in a number of plaque promoting
processes. OxLDL has been shown to be taken up by macro-
phages in a rapid and uncontrolled manner leading to the for-
mation of cholesterol ﬁlled foam cells, the major cellular
component of fatty streaks. OxLDL is also cytotoxic, causing
both necrosis and apoptosis in a variety of cell types including
macrophages [4–6]. The change from fatty streak to complex
plaque may be driven in part by the oxLDL induced death
of macrophages within the plaque [1].Abbreviations: LDL, low density lipoprotein; oxLDL, oxidized low
density lipoprotein; DTNB, 5,5 0-dithiobis (2-nitrobenzoic acid); PBS,
phosphate-buﬀered saline; SDS, sodium dodecyl sulfate
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doi:10.1016/j.febslet.2004.11.007The exact mechanism of oxLDL cytotoxicity is diﬃcult to
deﬁne. OxLDL contains a number of known cytotoxic
agents including oxysterol, reactive aldehydes such as 4-
hydroxynonenal (HNE), and various protein derivatives all
of which have been shown to cause macrophage cell death
[7,8]. OxLDL also can cause intracellular oxidative stress
by downregulating antioxidant enzymes or increasing the
production of reactive oxygen species such as hydrogen per-
oxide [9].
In suﬃcient concentrations, oxLDL will cause macrophage
cells to either undergo necrosis or apoptosis. Necrosis is char-
acterized by cytoplasmic swelling, disruption of internal organ-
elles, membrane lysis and release of cell debris into the
extracellular space. In contrast, apoptosis is an active and
highly regulated process resulting in the controlled shut down
of the cell with the formation of small membrane bound vesi-
cles that can be taken up by phagocytes. The features of apop-
tosis include morphological changes such as chromatin
condensation and margination, DNA fragmentation and
apoptotic body formation [5]. Typical biochemical changes
comprise cytochrome c release from mitochondria, activation
of cysteine-dependent caspases and labeling of the cell for
clearance by phagocytes through exposure of phosphatidylser-
ine on the surface of the cell [10]. In the absence of other cells
to engulf the apoptotic cells, secondary necrosis may follow
apoptosis [11].
The presence of caspase activation alone is often considered
deﬁnitive evidence of apoptosis, since their cleavage of struc-
tural and regulatory proteins is responsible for the irreversible
dismantling of the cell. Caspase activation has been found, or
implied through use of enzyme inhibitors, in THP-1 cells incu-
bated with oxLDL [10] and speciﬁc caspase assays in U937
cells incubated with hypochlorite-oxidized LDL [12]. In con-
trast, there is a growing awareness that apoptosis can proceed
in the absence of caspase activation, and there can be diﬀer-
ences in the quantiﬁcation of apoptosis depending on the
parameter being assessed [13]. This makes it often diﬃcult to
compare diﬀerent studies when only a limited number of apop-
tosis markers are measured.
Here, we report on our investigation into the cytotoxicity of
oxLDL in two diﬀerent human monocytic cell lines, THP-1
and U937 cells, using a variety of apoptosis markers. Phospha-
tidylserine exposure occurred in both cell types, but caspase
activation was only detected in the THP-1 cells. Absence of
caspase activity in the U937 cells was associated with a dra-
matic decrease in intracellular thiols upon treatment with
oxLDL.ation of European Biochemical Societies.
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All chemicals used were of AR grade or better and obtained from
the Sigma Chemical Company (USA) or BDH Chemicals New Zea-
land Limited unless otherwise indicated. Tissue culture media and plas-
ticware were supplied by Gibco (USA) through Life Technologies
(NZ). DTT was supplied by Boehringer–Mannheim. All solutions were
prepared using ion-exchanged ultra ﬁltered water prepared in a
NANOpure ultrapure water system from Barnstead/Thermolyne (IA,
USA).
2.1. Cell culture
THP-1 and U937 monocyte cultures were maintained in RPMI 1640
with 2 mM glutamine, 5% heat-inactivated fetal bovine serum, 100 U/
ml penicillin and 100 lg/ml streptomycin, in a humidiﬁed atmosphere
with 5% CO2 at a density of not more than 1 · 106/ml. During exper-
iments, cells were incubated for up to 48 h in RPMI 1640 alone at
5 · 105 cells/ml with or without native or oxLDL before washing in
warm sterile phosphate-buﬀered saline (PBS) to remove the oxidant
before analysis.
2.2. OxLDL preparation
EDTA-plasma was prepared from blood drawn by venipuncture
from fasting normolipidemic volunteers. LDL was isolated by a single
22-h ultracentrifugation using a four step discontinuous gradient in a
Beckman SW41 rotor. The LDL molar concentration was determined
by enzymatic cholesterol determination using the ‘‘Chol MPR 2’’ kit
supplied by Roche Chemicals (New Zealand) assuming an LDL molec-
ular weight of 2.5 MDa and a cholesterol content of 31.6% [14]. Puri-
ﬁed LDL was desalted by dialysis for 18 h against nitrogen-gassed
chelex-treated PBS (pH 7.4) and oxidized by incubation with 50 lM
CuSO4 solution for 24 h. Native and oxLDL were concentrated with
Uriﬁl-10 concentrators (Millipore, MA, USA) and sterilized through
a 0.22 lm membrane ﬁlter (Pall Gelman Laboratory) before addition
to the cells.2.3. Cell viability assays
The viability of the cells were measured using the MTT reduction
and the trypan blue exclusion assays [15]. MTT reduction analysis
was carried out using the method of Mosmann [16] but using 10%
w/v sodium dodecyl sulfate (SDS, ﬁnal concentration) to lyse the cells
and solubilize the insoluble MTT-formazan salt.2.4. Phosphatidylserine exposure and DNA fragmentation
Cells (105) were pelleted and suspended in binding buﬀer containing
Annexin V-FITC and propidium iodide (PI), as per the manufacturers
instructions (Apoptest-FITC A700 kit, Nexins Research). Following
10 min in the dark, 10000 cells were analyzed with a Vantage ﬂuores-
cence-activated cell sorter from Becton–Dickinson (San Jose, CA). The
cells were classiﬁed as viable, apoptotic or necrotic based on regions
drawn on the dot plots. Cells with low Annexin V-FITC and PI ﬂuo-
rescence were classiﬁed as viable, cells binding Annexin V-FITC but
excluding PI were classiﬁed as apoptotic and double labeled cells were
classiﬁed as necrotic [17].
To stain the cellular DNA, cells (106) were pelleted and ﬁxed in ice
cold 70% ethanol. The cells were then washed in PBS and incubated at
room temperature in 0.2 mM sodium phosphate containing 7 mM
citric acid (pH 7.8). After pelleting and washing in PBS, the cells were
suspended in 250 ll of PBS to which 10 lg RNAse A and 5 lg propi-
dium iodide were added. Following 10 min in the dark 20000 cells were
analyzed using the ﬂuorescence-activated cell sorter.2.5. Caspase-3 activity
After treatment, samples of 105 cells were pelleted by centrifugation
and stored at 80 C before analysis. For caspase analysis 100 ll of
buﬀer, containing 100 mM HEPES (N-(2-hydroxyethyl)piperazine-
N 0-(2-ethanesulfonic acid)), 10% sucrose, 0.1% Chaps (3-[(3-chlorami-
dopropyl)dimethylammonio]-1-propanesulfonate), 104% NP-40, 5
mM DTT and 50 lM DEVD-AMC (acetyl-asp-glu-val-asp-7-amido-
4-methyl-coumarin) at pH 7.25 was added to each pellet [18]. The
cleavage of the peptide substrate was monitored over 2 min by measur-
ing the increase in ﬂuorescence over time in a heat-jacketed F-4500Hitachi ﬂuorometer at kex 370 nm (band width 5 nm) and kem 445
nm (band width 10 nm) at 37 C. Fluorescence units were converted
to pmol of free AMC using a standard curve generated with reagent
AMC.
The conversion of pro-caspase-3 to its active form was measured by
western blotting with a mouse monoclonal caspase-3 antibody (E-8)
from Santa Cruz Biotechnology (CA, USA), in combination with a
peroxidase-linked anti-mouse IgG and ECL-2 chemiluminescence
from Amersham Bioscience NZ Ltd (Auckland, NZ).
2.6. Cellular reduced thiol concentration
After treatment cells were washed in cold PBS, then lysed by suspen-
sion and sonication in water. SDS (ﬁnal concentration of 10%) and
5,5 0-dithiobis (2-nitrobenzoic acid) [19] (DTNB, ﬁnal concentration
30 lM) was added to the lysate and incubated at room temperature
for 30 min before measuring the absorbance at 412 nm [20]. This anal-
ysis measures total cellular thiol content.2.7. Statistical analysis
All values in the text and ﬁgures are expressed as means ± S.D. of
triplicate treatments. Unless stated otherwise, results shown are from
single experiments, representative of a minimum of three. The data
were analyzed using the Statistica software package (Statsoft Inc.,
USA).3. Results
U937 or THP-1 cells were incubated in serum free RPMI
1640 with increasing concentrations of oxLDL for 48 h
(Fig. 1). Signs of toxicity were ﬁrst evident in the MTT reduc-
tion assay and trypan blue exclusion assay at 0.5 mg/ml
oxLDL, culminating in a 75% loss of viability at 3 mg/ml. In
contrast, native (unoxidized) LDL at 1.5 mg/ml actually pro-
tected the U937 cells from the background toxicity attributable
to culturing the cells in serum free media (Fig. 1).
Observation of morphological changes in the treated mono-
cytes suggested that while death was the ﬁnal endpoint in both
cell lines, the processes leading to a loss in viability were diﬀer-
ent (Fig. 2). In particular, THP-1 cells showed signs of mem-
brane blebbing and cell shrinkage 24 h after treatment (Fig.
2). In contrast, U937 cells had a more swollen appearance dur-
ing the ﬁrst 24 h after treatment, with the plasma membrane
more rounded than that of untreated cells (Fig. 2F and G ver-
sus E). Cellular destruction was clearly visible at 48 h (Fig.
2H). These observations suggested that THP-1 cells were
undergoing apoptosis, but a necrotic death was occurring in
U937 cells.
THP-1 and U937 cells were incubated with oxLDL for 48 h
and analyzed by ﬂow cytometry using Annexin V-FITC bind-
ing to measure phosphatidylserine externalization. Co-labeling
with propidium iodide allowed diﬀerentiation between apopto-
sis and necrosis, with control cells present in the lower left
quadrant, apoptotic cells in the lower right quadrant and ne-
crotic cells in the upper quadrants (Fig. 3A and B). Treatment
of the THP-1 cells with 0.5 mg/ml oxLDL caused a decrease in
viable cells with a rise in both phosphatidylserine externalized
apoptotic cells and necrotic cells (Fig. 3C). Higher oxLDL
concentrations caused the majority of the THP-1 cells to be-
come necrotic. In contrast, the U937 cells showed little change
in phosphatidylserine externalization and propidium iodide
staining at 0.5 mg/ml oxLDL, but at 1.5 mg/ml oxLDL there
was a large loss in control cells and an increase in both apop-
totic and necrotic cells (Fig. 3D). At 3 mg/ml oxLDL all the
U937 cells were necrotic. A cell cycle analysis was undertaken
Fig. 2. Morphological changes in monocytes treated with oxLDL.
THP-1 cells (A–D) and U937 cells (E–H) were incubated with 1.5 mg/
ml OxLDL for 0 (A,E), 6 (B,F), 24 (C,G) and 48 (D,H) h before being
photographed with a reversed-phase light microscope.









































Fig. 1. OxLDL decreases cell viability of human monocyte cell lines.
THP-1 cells (A) and U937 cells (B) (5 · 105cells/ml) were incubated
with varying concentrations of OxLDL in serum free RPMI 1640. Cell
viability was determined after 48 h by MTT reduction (open bars) and
trypan blue exclusion analysis (solid bars). A non-oxidized LDL
(nLDL) at 1.5 mg/ml was included as an additional control. The results
are expressed as a mean percentage of triplicates ± S.D. of control cells
incubated in LDL free media.
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(Fig. 3E–H). In U937 cells incubated with 1.5 mg/ml oxLDL
there was a loss of cells in the G0/G1 phase, with an increase
of cells in the G2/M (Fig. 3G and H). Very few cells were pres-
ent in the sub G0/G1 fraction, dispite 25% of the cells being
phosphatidylserine-positive after 48 h (Fig. 3D). We therefore
conclude that oxLDL is not triggering DNA fragmentation in
the U937 cells.
Measurement of caspase-3 like DEVDase activity showed
that oxLDL caused a signiﬁcant and concentration dependent
increase in caspase activation in THP-1 cells (Fig. 4A). The
rate of activation was dependent on the oxLDL concentration
with 0.2 mg/ml oxLDL causing activation between 24 and 48 h
while a signiﬁcant rise in activity was observed with 3 mg/ml
oxLDL after only 6 h. With 0.5 and 1.5 mg/ml oxLDL there
was no signiﬁcant rise in caspase-3 activity until after 12 h of
incubation. At the lower concentrations of oxLDL (0.2–0.5
mg/ml), caspase activation was continuing to increase over
the 48 h, consistent with optimal PS exposure observed with
these concentrations of oxLDL. The two highest doses of
oxLDL (1.5–3 mg/ml) caused the caspase activity to peak
and then fall. This proﬁle, along with the ﬂow cytometry data
(Fig. 3C), suggests the higher concentrations of oxLDL cause a
shift from apoptosis to secondary necrosis. In dramatic con-
trast to the THP-1 cells, there was no major increase in caspase
activity in the U937 cells treated with oxLDL (Fig. 4B). In-stead, at concentrations of 0.5 mg/ml and greater there was a
small but signiﬁcant decrease in background caspase activity,
ﬁrst detectable 12 h after treatment. Consistent with the activ-
ity assays, Western blotting showed conversion of pro-caspase-
3 to its active form only occurred in the THP-1 cells (Fig. 4C).
Decreased caspase activity has been observed in cells placed
under excess oxidative stress, consistent with the observation
that the active site cysteine of the caspases has to be reduced
to be active [21,22]. To explore this possibility, we measured
total thiol levels in the cells following treatment with oxLDL.
This analysis measured the combined cellular glutathione and
protein thiols content. There was a concentration-dependent
loss in thiols in THP-1 cells (Fig. 4D), but this was consistent
with the loss in cell viability (Fig. 1). In contrast, there was a
more marked loss of reduced thiols in the U937 cells. At 1.5
mg/ml oxLDL there was an almost complete loss of reduced
thiols (Fig. 4D), yet a large number of U937 cells retained their
viability (Fig. 1). A time course showed that the U937 cells lost
their intracellular thiols between 6 and 12 h after the addition
of the oxLDL (Fig. 4E). This loss was closely paralleled by a
decrease in basal caspase activity suggesting that oxLDL in-
duced stress was interfering with caspase activation in the
U937 cells.
Fig. 3. Flow cytometery analysis of oxLDL-treated cells. Cells were incubated for 48 h at 5 · 105 cells/ml in RPMI 1640 with or without oxLDL,
before staining and analysis on a FACS Vantage ﬂow cytometer. To assess phosphatidylserine exposure, the cells were co-stained with annexin V-
FITC and propidium iodide. A representative experiment showing 5000 U937 cells treated with (A) 0 and (B) 1.5 mg/ml oxLDL is presented. OxLDL
was added to (C) THP-1 and (D) U937 cells at a range of concentrations. The open bars represent control cells, hatched bars the apoptotic cells and
solid bars the necrotic cells. Values are the means ± S.D. of three independent experiments. To measure cellular DNA degradation THP-1 cells (E,F)
or U937 (G,H) cells with (F,H) or without (E,G) 1.5 mg/ml oxLDL were incubated for 48 h in RPMI 1640. The cells were ﬁxed and their DNA was
stained with propidium iodide before analysis by ﬂow cytometry.
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In this study, we have shown that oxLDL triggers apoptosis
in monocytic cell lines, but the nature of the apoptotic pro-
gram varies dramatically depending on the cell type. In the
THP-1 cells, apoptosis proceeds via a conventional pathway
that includes caspase activation, phosphatidylserine exposure,
and ﬁnally a loss in cell viability with a corresponding decline
in intracellular reduced thiols. In contrast, U937 cells show an
early decline in reduced thiols and phosphatidylserine
exposure occurs in the absence of any discernable caspase
activation.
U937 cells have a functional caspase network that is acti-
vated by a range of apoptotic stimuli [23,24]. Consistent withour results, Lizard et al. [25] observed only minor cleavage
of pro-caspase-3 after incubation of U937 cells with 7-ketocho-
lesterol, a component of oxLDL. However, Vicca et al. [12]
were able to measure signiﬁcant caspase activity in U937 cells
treated with hypochlorous acid-oxidized LDL, suggesting that
this may act diﬀerently from the Cu-oxidized LDL used in this
study.
The response of the U937 cells is similar to what has been
observed previously with stimulated neutrophils. Products of
the neutrophil oxidative burst trigger phosphatidylserine expo-
sure, but do so in the absence of caspase activation [26]. Casp-
ases have a redox-sensitive cysteine at their catalytic site, and
oxidation of this residue may prevent auto-proteolytic activa-
tion of the caspase cascade. Dithiothreitol is included with
Fig. 4. Caspase activation and thiol loss in monocytes treated with oxLDL. THP-1 (A) and U937 cells (B) were incubated in RPMI 1640 with
varying concentrations of oxLDL for up to 48 h. The cells were washed, caspase buﬀer added and the cleavage of the substrate monitored as increase
in ﬂuorescence over time at 37 C. Fluorescence units were converted to pmol of free AMC using a standard curve generated with reagent AMC. (C)
A Western blot for caspase-3 is present showing: Lane 1 = untreated U937 cells; lane 2 = U937 cells with 1.5 mg/ml oxLDL for 24 h; lane
3 = untreated THP-1 cells; lane 4 = THP-1 cells with 1.5 mg/ml oxLDL for 24 h. Arrows indicate the active 17 kDal and 20 kDal forms of caspase-3.
The 32 kDal band for pro-caspase-3 is overexposed to enable visualization of the active forms. (D) THP-1 and U937 cells were incubated at
5 · 105cells/ml in RPMI 1640 for 48 h with or without native or oxidized LDL and the levels of reduced total thiols analyzed using the DTNB thiol
assay. (E) Time course of U937 cell viability (MTT reduction), caspase activity and total cellular thiol loss over 48 h. Values are expressed as the
means ± S.D. of triplicates.
S.K. Baird et al. / FEBS Letters 578 (2004) 169–174 173puriﬁed caspases to maintain catalytic competency [27], and
the enzymes are also sensitive to inactivation by a range of
reactive oxygen and nitrogen species [22,28]. Alternatively,
other redox-sensitive proteins critical for the initiation of
apoptosis may be prevented from functioning.
Components of the oxLDL could selectively oxidize cellular
thiol proteins, or promote global oxidation by impacting on
the glutathione- and thioredoxin-dependent reduction path-
ways. In U937 cells the loss of reduced thiols and the inactiva-
tion of caspases by oxLDL occurred in the same pattern over
time, indicative of global intracellular oxidation (Fig. 4). The
loss of all background caspase activity in the U937 cells treated
with oxLDL emphasizes the intensity of the oxidative stress
present in these cells.
The diﬀerence in response between U937 and THP-1 cells to
oxLDL is intriguing and may relate to varying mechanisms ofuptake of the oxLDL. U937 cells express fourfold higher levels
of CD36 scavenger receptor than do THP-1 cells [29]. This
may result in an initial burst of oxLDL uptake and a more
intensive oxidative stress. The two cell lines also have other
noted diﬀerences in their response to oxidative stress. U937
cells do not express the transcriptional regulator peroxisome
proliferator-activated receptor-c in response to oxLDL [30],
as THP-1 cells do. This response is believed to be mediated
via the oxidized lipids in copper-oxidized LDL. U937 cells also
have a lower level of glutathione expression but higher
MnSOD than THP-1 cells [31]. How this will aﬀect the poten-
tial cellular stress induced by the oxLDL is diﬃcult to deter-
mine from the current literature.
In conclusion, oxLDL is able to trigger diﬀerent forms of
apoptosis, even between two human monocytic cell types.
The diﬀerence in response is likely to depend upon the
174 S.K. Baird et al. / FEBS Letters 578 (2004) 169–174handling of the oxLDL, and the redox environment of the tar-
get cell. We suggest that the exact pathways of apoptotic cell
death initiated by oxLDL may vary in the atherosclerotic le-
sion depending on the cell type and the local environment.
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